PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: HealthEd Group, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

HealthEd to Present At 2012 Patient Adherence Summit - HealthEd will present “Adherence Begins Before Treatment: 5 Strategies You Must Consider To Drive Effective Patient Interaction” at the 2nd Annual Patient Adherence Summit in Philadelphia - HealthEd.com
HealthEd to Present At 2012 Patient Adherence Summit

 

NewswireToday - /newswire/ - Clark, NJ, United States, 2012/02/22 - HealthEd will present “Adherence Begins Before Treatment: 5 Strategies You Must Consider To Drive Effective Patient Interaction” at the 2nd Annual Patient Adherence Summit in Philadelphia - HealthEd.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Patient Adherence Summit, produced by ExL Pharma, aims to provide an interactive forum to understand and remove patient-specific barriers to non-adherence. Non-adherence has a deep impact on society, including increased hospital admissions and as many as 125,000 US deaths each year, according to conference organizers.

Liz Carden, MPH, CHES, Manager, Health Education, and Marissa Addalia, Vice President, will present on behalf of HealthEd.

Carden is responsible for research and development of wellness programming and literature, specializing in chronic health conditions and medication adherence. During her time at HealthEd, she has worked on programs for both healthcare professionals and patients focusing on diseases such as arthritis, cardiovascular conditions, multiple sclerosis, cancer, fibromyalgia, hemophilia, and osteoporosis. Previously she was the community and public health manager at the Eastern Pennsylvania Chapter of the Arthritis Foundation. Carden received her bachelor's degree from Misericordia University and her master's of public health, with a focus on community health and prevention, from Drexel University.

Addalia brings nearly 10 years of experience in pharmaceutical marketing and education. She has spent the past 5 years at HealthEd, where her priority has been helping clients solve complex business problems and create optimal patient experiences. Marissa has a passion for research and the voice of the patient, and she works with her cross-functional team to ensure insights are carried through project development. She is equally passionate about clients’ experiences with HealthEd and seeks to connect the dots that keep clients up at night.

About HealthEd

HealthEd (HealthEd.com) improves the patient experience by providing strategy, multi-channel creative development, and educational solutions for leading healthcare companies. Our work yields deeper insight into the patient journey, more effective patient-provider dialogue, and improved treatment adherence. To learn more about working with us, please visit the website or contact Marissa Addalia, Vice President, at 908-379-2018.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: HealthEd Group, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


HealthEd to Present At 2012 Patient Adherence Summit

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mary Lou Szekeres - HealthEd.com 
732-587-2707 m.szekeres[.]healthed.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any HealthEd Group, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From HealthEd Group, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Deb Sheppard - Medium Psychic Author Speaker





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)